Caxton Associates (New York)’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-11,667
Closed -$259K – 553
2023
Q3
$259K Buy
+11,667
New +$310K 0.04% 325
2022
Q4
– Sell
-55,507
Closed -$1.74M – 628
2022
Q3
$1.74M Buy
55,507
+46,029
+486% +$1.71M 0.23% 42
2022
Q2
$359K Buy
+9,478
New +$407K 0.03% 337
2020
Q2
– Sell
-16,820
Closed -$770K – 645
2020
Q1
$770K Buy
+16,820
New +$854K 0.14% 88
2019
Q3
– Sell
-7,757
Closed -$424K – 556
2019
Q2
$424K Buy
+7,757
New +$412K 0.05% 219
2019
Q1
– Sell
-4,063
Closed -$278K – 500
2018
Q4
$278K Buy
+4,063
New +$315K 0.04% 199
2018
Q2
– Sell
-13,700
Closed -$897K – 488
2018
Q1
$897K Sell
13,700
-937
-6% -$66.9K 0.05% 203
2017
Q4
$1.06M Buy
14,637
+6,337
+76% +$446K 0.05% 202
2017
Q3
$641K Buy
+8,300
New +$665K 0.02% 253
2014
Q3
– Sell
-70,000
Closed -$5.19M – 263
2014
Q2
$5.19M Buy
+70,000
New +$4.89M 0.27% 74

Other funds holding WBA

Caxton Associates (New York)'s WBA Position: Q4 2023 in Review

Caxton Associates (New York) sold out of Walgreens Boots Alliance (WBA) in Q4 2023, closing a stake of 11,667 shares — an estimated $259K sold.

Caxton Associates (New York) first reported a position in WBA in Q2 2014 and held it in 10 quarters. The position peaked at $5.19M in Q2 2014. 1,071 funds tracked by Wall St. Rank hold WBA as of Q4 2023.

  • Caxton Associates (New York) reported no remaining Walgreens Boots Alliance position as of Q4 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 11,667 Walgreens Boots Alliance shares in Q4 2023, an estimated $259K.
  • Caxton Associates (New York) first reported a position in Walgreens Boots Alliance in Q2 2014 and held it in 10 quarters.
  • Caxton Associates (New York)'s Walgreens Boots Alliance position peaked at $5.19M in Q2 2014.
  • 1,071 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2023.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.